Clinical Trial Update: Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating quadruple therapy with eltrombopag for thrombocytopenia in chronic hepatitis C was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Thrombocytopenia, Hepatitis C | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2019-10-22